Fidaxomicin is a narrow-spectrum antibiotic used primarily to treat infections caused by Clostridioides difficile (C. difficile). This bacterium is responsible for a significant number of hospital-acquired infections, leading to severe diarrhea and colitis. Unlike broad-spectrum antibiotics, fidaxomicin specifically targets C. difficile, making it a crucial tool in managing outbreaks.
